Download PDF

Other users also viewed these articles

Eligibility for finerenone in real-world patients with diabetes and chronic kidney disease: Insights from the FIDELITY pooled analysis Alberto Esteban-Fernández, Carlos de Blas-Ruiz, Maitane Fernández-Ustoa, Elena Gabaldón-Perucha, Beatriz López-Gómez, Guadalupe Ruiz-Martín
10.1016/j.nefroe.2025.101315
Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease Jose Luis Górriz, José Ramón González-Juanatey, Lorenzo Facila, Maria Jose Soler, Alfonso Valle, Alberto Ortiz
10.1016/j.nefroe.2023.09.002
Cardiovascular and renal outcomes according to KDIGO stages of chronic kidney disease in the Spanish population: Insights from real-world evidence Rafael Santamaria, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Ignacio Hernández, Ana Cebrián, Roberto Alcázar, Manuel Gorostidi
10.1016/j.nefroe.2025.501340